LIMERICK, Ireland — February 25, 2026 — Leads & Copy —
Kneat.com, inc., a leader in digitizing and automating validation and quality processes, released its annual shareholder letter today, highlighting the durability of its growth and the opportunities ahead. The company grew software revenue by 33% and welcomed a record number of new customers in 2025. The company’s Annual Recurring Revenue (ARR) has scaled organically to more than $74 million, supported by a Net Revenue Retention (NRR) rate of 115% in 2025.
CEO Eddie Ryan thanked shareholders for their continued confidence in Kneat, emphasizing the essential role the platform plays in helping life sciences organizations operate with compliance, consistency, and efficiency. Ryan noted the company’s strength amid increased macro uncertainty. He said that while many enterprise software companies faced delayed buying cycles and scrutiny about the impact of artificial intelligence, Kneat delivered strong performance.
According to the company, recent commentary has raised concerns about potential AI substitution in SaaS, concerns that apply least in the highly regulated, mission-critical environments where Kneat operates. Kneat serves life sciences manufacturers, where compliance, traceability, and data integrity are non-negotiable. The company emphasizes that enterprise software in this context is a trust-driven business, and Kneat has earned that trust through years of proven performance.
Kneat says it is purpose-built for validation in regulated environments. Every action within the platform is attributable, traceable, auditable, and preserved for long-term regulatory review. This architecture and its data integrity are difficult to replicate, giving the company a competitive advantage.
Kneat says that AI is not a threat but an accelerant. In 2025, the company introduced AI capabilities designed for GxP-aligned environments, including a content review assistant, natural-language process analysis, a user-support chatbot, and instant language translation. The company says that its AI roadmap includes deeper automation across lifecycle documentation, risk management, workflows, and end-to-end process optimization.
According to the company, Kneat earned a 98/100 G2 Satisfaction Score, the highest in the Pharma and Biotech category, and maintains a Net Promoter Score above 70. Its team also won a Gold Stevie® Award for global tech support.
Kneat Solutions provides companies in regulated industries with efficiency in validation and compliance through its digital validation platform, Kneat Gx. Kneat Gx is ISO 9001 and ISO 27001 certified, validated, and 21 CFR Part 11/Annex 11 compliant. The company says that studies have shown that Kneat Gx reduces man-hours associated with validation documentation by up to 50% and accelerates review and approval cycles by up to 50%.
Source: kneat.com
